Titre : | Medical cannabis: aligning use to evidence-based medicine approach (2018) |
Auteurs : | L. BAR-LEV SCHLEIDER ; R. ABUHASIRA ; V. NOVACK |
Type de document : | Article : Périodique |
Dans : | British Journal of Clinical Pharmacology (Vol.84, n°11, November 2018) |
Article en page(s) : | 2458-2462 |
Langues: | Anglais |
Discipline : | PRO (Produits, mode d'action, méthode de dépistage / Substances, action mode, screening methods) |
Mots-clés : |
Thésaurus géographique ISRAELThésaurus mots-clés DONNEE PROBANTE ; CANNABIS ; USAGE THERAPEUTIQUE ; RECHERCHE |
Résumé : | During the past decade we have been witnessing a rise in medical cannabis use, yet the evidence for the safety and efficacy of the various cannabinoid compounds is scarce. The State of Israel has always been at the forefront of clinical and translational research in support of Evidence Based Medicine. With respect to cannabis Israel has created a medical and regulatory environment that enables clinical studies with cannabis which may lead to improved Evidence Based use of these compounds. This opinion paper discusses selected studies into the safety and effects of cannabis derived products. |
Domaine : | Drogues illicites / Illicit drugs |
Refs biblio. : | 38 |
Affiliation : | Cannabis Clinical Research Institute, Soroka University Medical Center and Faculty of Health Sciences, Ben-Gurion University of the Negev, Israel |
Lien : | https://doi.org/10.1111/bcp.13657 |
Accueil